Amicus Price To Sales Ratio from 2010 to 2024
| FOLD Stock | USD 10.28 0.11 1.08% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 10.4878466 | Current Value 9.96 | Quarterly Volatility 144.30740347 |
Check Amicus Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amicus main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.3 M, Interest Expense of 52.7 M or Other Operating Expenses of 496.5 M, as well as many exotic indicators such as Price To Sales Ratio of 9.96, Dividend Yield of 0.0 or PTB Ratio of 27.46. Amicus financial statements analysis is a perfect complement when working with Amicus Therapeutics Valuation or Volatility modules.
Amicus | Price To Sales Ratio |
Latest Amicus Therapeutics' Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Amicus Therapeutics over the last few years. Price to Sales Ratio is figured by comparing Amicus Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Amicus Therapeutics sales, a figure that is much harder to manipulate than other Amicus Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period. Amicus Therapeutics' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amicus Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 7.90 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Amicus Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 90.39 | |
| Geometric Mean | 31.86 | |
| Coefficient Of Variation | 159.65 | |
| Mean Deviation | 99.46 | |
| Median | 19.51 | |
| Standard Deviation | 144.31 | |
| Sample Variance | 20,825 | |
| Range | 500 | |
| R-Value | (0.39) | |
| Mean Square Error | 18,996 | |
| R-Squared | 0.15 | |
| Significance | 0.15 | |
| Slope | (12.62) | |
| Total Sum of Squares | 291,545 |
Amicus Price To Sales Ratio History
About Amicus Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Amicus Therapeutics income statement, its balance sheet, and the statement of cash flows. Amicus Therapeutics investors use historical funamental indicators, such as Amicus Therapeutics's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Amicus Therapeutics investors may use each financial statement separately, they are all related. The changes in Amicus Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Amicus Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Amicus Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Amicus Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 10.49 | 9.96 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Amicus Therapeutics Correlation against competitors. For information on how to trade Amicus Stock refer to our How to Trade Amicus Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Amicus Stock analysis
When running Amicus Therapeutics' price analysis, check to measure Amicus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amicus Therapeutics is operating at the current time. Most of Amicus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Amicus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amicus Therapeutics' price. Additionally, you may evaluate how the addition of Amicus Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Amicus Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amicus Therapeutics. If investors know Amicus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amicus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Revenue Per Share 1.353 | Quarterly Revenue Growth 0.306 | Return On Assets (0.06) | Return On Equity (1.07) |
The market value of Amicus Therapeutics is measured differently than its book value, which is the value of Amicus that is recorded on the company's balance sheet. Investors also form their own opinion of Amicus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Amicus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amicus Therapeutics' market value can be influenced by many factors that don't directly affect Amicus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amicus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amicus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amicus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.